Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ASC. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114163436A details a novel Pd-catalyzed one-step synthesis of indolizine derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN115353511A details a safe, one-pot palladium-catalyzed carbonylation method for synthesizing complex biheterocycles, offering significant cost and safety advantages.
Patent CN113880781B reveals glucose-based synthesis for trifluoromethyl triazoles. Offers mild conditions, biomass sourcing, and scalable manufacturing for pharmaceutical intermediates.
Patent CN111039737B reveals a visible-light catalyzed route for sulfone intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Discover a novel green synthesis for alpha-cyano-beta-amino acrylates via ammonium salt catalysis. High purity, scalable pharma intermediates with reduced environmental impact.
Patent CN113880781B reveals glucose-based route for triazoles. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN113880781B details glucose-based synthesis for trifluoromethyl-triazoles. This method offers mild conditions and scalable production for reliable pharmaceutical intermediates supply chains.
Patent CN114163436A reveals a novel Pd-catalyzed route to bioactive indolizine derivatives. Discover cost-effective manufacturing and supply chain advantages for API intermediates.
Patent CN115353511A details a novel Pd-catalyzed multi-component route for carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Efficient one-pot synthesis of 3-cyanoindoles using copper catalysis. Reduces steps and toxic reagents for pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed method for indolone structures reduces steps and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel glucose-based route for trifluoromethyl triazoles offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113880781B reveals glucose-based synthesis for triazoles. Enables cost reduction in API intermediate manufacturing and reliable supply chain solutions.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN113880781B reveals glucose-based synthesis for trifluoromethyl triazoles. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable biomass sources.
Patent CN115353511A details a novel Pd-catalyzed multicomponent route for carbonyl-bridged biheterocycles, offering safer processing and cost reduction in API manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel glucose-based route for 3-CF3-1,2,4-triazoles. Mild conditions, high efficiency, scalable process for pharmaceutical intermediates.
Patent CN113880781B reveals glucose-based triazole synthesis offering cost reduction and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN113880781B reveals glucose-based synthesis. Offers cost and supply chain benefits for pharmaceutical intermediates manufacturing globally.